Abstract. Background:. Drug-coated balloons (DCBs) have emerged as potential alternatives to drug-eluting stents in specific lesion subsets for de novo coronary lesions. Quantitative flow ratio (QFR) is a method based on the three-dimensional quantitative coronary angiography and contrast flow velocity during coronary angiography (CAG), obviating the need for an invasive fractional flow reserve procedural. This study aimed to assess the serial angiographic changes of de novo lesions post-DCB therapy and further explore the cut-off values of lesion and vessel QFR, which predict vessel restenosis (diameter stenosis [DS] ≥50%) at mid-term follow-up. Methods:. The data of patients who underwent DCB therapy between January 2014 and December 2019...
AbstractObjectives. The aim of this study was to determine which quantitative angiographic variable ...
Purpose: Wire-based coronary physiology pullback performed before percutaneous coronary intervention...
BackgroundDrug-coated balloons (DCB), alone or in combination with drug-eluting stents (DES), may be...
ObjectivesThis study sought to elucidate the underlying mechanism through which drug-eluting balloon...
Background: Investigating the prognostic value of the Murray law-based quantitative flow ratio (μQFR...
Objectives: The aim of this study was to investigate the impact of post–percutaneous coronary interv...
Objectives Although drug-coated balloons (DCBs) are established for de-novo lesions in small coronar...
Objective: To evaluate the long-term efficacy of three currently available drug coated balloons (DCB...
© 2018 Wiley Periodicals, Inc. Background: Studies comparing drug coated balloons (DCB) with new gen...
Background: The safety and efficacy of drug-coated balloon (DCB) treatment for de novo coronary chro...
BACKGROUND: There are few data of clinical outcomes after drug-coated balloon (DCB) angioplasty ...
OBJECTIVES. The aim of this study was to determine which quantitative angiographic variable best des...
Objective: The aim of this study was to evaluate the mid-term efficacy of drug-coated balloons (DCB)...
The aim of the PICTURE study is to relate arterial wall morphology on intracoronary ultrasound image...
\u3cp\u3eBackground - After regular coronary balloon angioplasty, it would be helpful to identify th...
AbstractObjectives. The aim of this study was to determine which quantitative angiographic variable ...
Purpose: Wire-based coronary physiology pullback performed before percutaneous coronary intervention...
BackgroundDrug-coated balloons (DCB), alone or in combination with drug-eluting stents (DES), may be...
ObjectivesThis study sought to elucidate the underlying mechanism through which drug-eluting balloon...
Background: Investigating the prognostic value of the Murray law-based quantitative flow ratio (μQFR...
Objectives: The aim of this study was to investigate the impact of post–percutaneous coronary interv...
Objectives Although drug-coated balloons (DCBs) are established for de-novo lesions in small coronar...
Objective: To evaluate the long-term efficacy of three currently available drug coated balloons (DCB...
© 2018 Wiley Periodicals, Inc. Background: Studies comparing drug coated balloons (DCB) with new gen...
Background: The safety and efficacy of drug-coated balloon (DCB) treatment for de novo coronary chro...
BACKGROUND: There are few data of clinical outcomes after drug-coated balloon (DCB) angioplasty ...
OBJECTIVES. The aim of this study was to determine which quantitative angiographic variable best des...
Objective: The aim of this study was to evaluate the mid-term efficacy of drug-coated balloons (DCB)...
The aim of the PICTURE study is to relate arterial wall morphology on intracoronary ultrasound image...
\u3cp\u3eBackground - After regular coronary balloon angioplasty, it would be helpful to identify th...
AbstractObjectives. The aim of this study was to determine which quantitative angiographic variable ...
Purpose: Wire-based coronary physiology pullback performed before percutaneous coronary intervention...
BackgroundDrug-coated balloons (DCB), alone or in combination with drug-eluting stents (DES), may be...